CONSOLIDATED INTERIM REPORT FOR III QUARTER AND 9 MONTHS OF

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CONSOLIDATED INTERIM REPORT FOR III QUARTER AND 9 MONTHS OF 2015 (UNAUDITED)

During the third quarter of 2015 Pro Kapital continued the construction works of the new T1 shopping and entertainment centre in Tallinn, which is the Company´s largest single-object development project. Active negotiations with several local and international retail operators were carried on with over 55% of the leasable area being covered with signed lease agreements. The Company continued also the construction works in two of its residential development projects – Šaltinių Namai in Vilnius and Tondi Quarter in Tallinn.

Total revenue for nine months of 2015 was 12,9 million euros, an increase of 58% compared to the reference period (2014 9 months: 8,2 million euros). Net operating result during nine months increased by 0,8 million euros (47%) compared to the reference period, totalling to losses of 0,9 million euros (2014 9 months loss of 1,7 million euros). Net operating profit for the third quarter was 0,5 million euros (2014 Q3 loss of 0,5 million euros). Net result for nine months of 2015 has increased by 0,1 million euros (3%) compared to the reference period, totalling to losses of 2,8 million euros (2014 9 months loss of 2,9 million euros). Net result for the third quarter was loss of 1,3 million euros (2014 Q3 loss of 0,9 million euros).

Presales for Vilnius Šaltinių Namai project and Tallinn’s Tondi residential quarter have been successfully continued. At the moment of issuing interim report 18 premises out of 19 in Vilnius K7 building have been sold (notary deeds concluded for 18 of them) and reservations for 25 apartments out of 44 in K4-1 building have been signed. In Tallinn, Tondi quarter, by the moment of issuing the present report the first building of Marsi Street has been completed, 27 apartments have been handed over to the clients and 4 out of 31 apartments are yet on sale. In the second building 6 apartments have been handed over to the clients, 9 presale agreements have been signed and in the third building 11 presale agreement have been signed. For Kliversala project in Riga 8 presale agreements have been signed out of 49 apartments.

Key financial figures

  2015 9M 2014 9M 2015 Q3 2014 Q3
         
Revenue, th EUR 12 911 8 161 3 017 2 252
Gross profit, th EUR 3 327 2 339 960 929
Gross profit, % 26% 29% 32% 41%
Operating result, th EUR -906 -1 720 -466 -529
Operating result, % -7% -21% -15% -23%
Net result, th EUR -2 833 -2 906 -1 253 -946
Net result, % -22% -36% -42% -42%
         
Earnings per share, EUR -0,05 -0,05 -0,02 -0,02
         
  30.09.2015 31.12.2014 30.09.2014  
         
Total Assets, th EUR 127 522 125 031 98 531  
Total Liabilities, th EUR 45 136 39 243 36 204  
Total Equity, th EUR 82 386 85 788 62 201  
Debt/ Equity * 0,55 0,46 0,58  
         
         
Return on Assets, % ** -2,2% 17,9% -2,9%  
Return on Equity, % *** -3,6% 26,1% -4,7%  
         
Net asset value per share, EUR **** 1,52 1,59 1,15  

Consolidated interim statements of financial position

 

in thousands of euros Notes 30.09.2015 31.12.2014
       
ASSETS      
Current Assets      
  Cash and cash equivalents   8 244 1 881
  Current receivables   1 079 2 463
  Inventories   12 597 14 535
Total Current Assets   21 920 18 879
         
Non-Current Assets      
  Non-current receivables   50 150
  Property, plant and equipment 5 17 162 17 619
  Investment property                   6 88 110 88 110
  Intangible assets   280 273
Total Non-Current Assets   105 602 106 152
       
TOTAL ASSETS   127 522 125 030
in thousands of euros Notes 30.09.2015 31.12.2014
LIABILITIES AND EQUITY      
Current Liabilities      
  Current debt                                                          7 7 171 16 348
  Customer advances   1 707 1 548
  Current payables   3 002 4 761
  Taxes payable   415 177
  Short-term provisions   91 5
Total Current Liabilities   12 386 22 839
         
Non-Current Liabilities      
  Long-term debt  7 29 650 13 430
  Other long-term liabilities   10 79
  Deferred income tax liability   2 677 2 744
  Long-term provisions   413 151
Total Non-Current Liabilities   32 750 16 404
       
TOTAL LIABILITIES   45 136 39 243
         
Equity attributable to equity holders of the parent      
  Share capital in nominal value   10 821 10 821
  Paid in capital   1 474 1 474
  Statutory reserve   1 082 1 064
  Revaluation reserve   9 389 9 389
  Foreign currency differences   -143 -143
  Retained earnings   61 141 39 778
  Profit/ loss for the period   -2 935 21 381
Total equity attributable to equity holders of the parent   80 829 83 764
       
Non-controlling interest   1 557 2 024
TOTAL EQUITY   82 386 85 788
       
TOTAL LIABILITIES AND EQUITY   127 522 125 031

Consolidated interim statements of comprehensive income

in thousands of euros Notes 2015 9M 2014 9M 2015 Q3 2014 Q3
           
Operating income          
Revenue 8 12 911 8 161 3 017 2 252
Cost of goods sold 9 -9 584 -5 822 -2 057 -1 323
Gross profit 10 3 327 2 339 960 929
           
Marketing expenses   -414 -375 -121 -132
Administrative expenses 11 -3 755 -3 981 -1 367 -1 651
Other income   204 357 110 122
Other expenses   -268 -60 -48 203
Operating profit (loss)   -906 -1 720 -466 -529
           
Financial income 12 11 44 2 3
Financial expense 12 -1 922 -1209 -787 -413
Profit (loss) before income tax   -2 817 -2 885 -1 251 -939
Income tax   -16 -21 -2 -7
Net profit (loss) for the period   -2 833 -2 906 -1 253 -946
           
           
           
Equity holders of the parent   -2 935 -2 770 -1 232 -824
Non-controlling interest   102 -136 -21 -122
           
           
Earnings per share (EUR) 13 -0,05 -0,05 -0,02 -0,02
Diluted earnings per share (EUR) 13 -0,05 -0,05 -0,02 -0,02

 

Consolidated interim statements of cash flows

in thousands of euros Note 2015 9M 2014 9M 2015 Q3 2014 Q3
           
Cash flows from operating activities          
Profit (loss) for the year   -2 833 -2 906 -1 253 -946
Adjustments for:          
     Depreciation and amortisation of non-current assets 5 504 527 158 202
     Change in fair value of investment property 6 206 560 26 299
     Gain/loss from sale of PPE   0 -3 0 -1
     Gain/loss from disposal of subsidiary 4 0 -19 0 0
     Finance income and costs, net 12 1 911 1 121 785 292
     Other non-monetary changes (net amounts)   229 647 164 115
Movements in working capital:          
     Change in trade receivables and prepayments 1 384 -495 4 -363
     Change in inventories   1 937 -1 181 -505 -1 902
     Change in liabilities and prepayments   -1 362 2 350 -842 1 526
     Change in provisions   346 -42 340 -21
Net cash generated by operating activities 2 322 559 -1 125 -799
         
Cash flows from investing activities          
Payments for property, plant and equipment 5 -50 -79 -10 -45
Proceeds from disposal of property, plant and equipment   0 7 0 1
Payments for intangible assets   -13 0 -13 0
Payments for investment property 6 -206 -560 -26 -299
Proceeds from disposal of subsidiaries   0 142 0 142
Interest received   4 6 1 2
Net cash used in investing activities   -265 -484 -48 -199
           
Cash flows from financing activities          
Proceeds from non-convertible bonds   7 652 547 652 247
Repurchase of convertible bonds   -62 0 0 0
Proceeds from borrowings   2 808 1 840 611 493
Repayment of borrowings   -4 219 -2 265 -514 -188
Interest paid   -1 873 -1 062 -1 193 -480
Net cash used in/ generated by financing activities   4 306 -940 -444 72
           
Net change in cash and cash equivalents 6 363 -865 -1 617 -926
           
Cash and cash equivalents at the beginning of the period 1 881 2 759 9 861 2 820
Cash and cash equivalents at the end of the period 8 244 1 894 8 244 1 894

 

         Allan Remmelkoor          Member of the Management Board          Tel.: +372 6144 920          Email: prokapital@prokapital.ee

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Sandler Partners Unveils 2025 Superstar Trip Destination

Updated Category News Views 179

Sandler Partners Unveils 2025 Superstar Trip Destination Sandler Partners is thrilled to reveal the highly anticipated location for its 2025 Superstar Trip, a special reward designed to honor Partners who have excelled in achieving their growth objectives for the year. The trip will take place at the stunning Susurros del Corazón Resort, located along the picturesque...

Continue Reading
e.l.f. Beauty Stock Insights: Understanding Market Trends Today

Updated Category News Views 309

Market Sentiment Surrounding e.l.f. Beauty Investors with substantial capital are showing a cautious approach towards e.l.f. Beauty (NYSE: ELF). This sentiment isn't just noise in the market; it reflects deeper strategies that should be on the radar of traders and analysts alike. There has been significant insight gleaned from public options activity which suggests that...

Continue Reading
Empowering Teens Through Free AI Bootcamp by Mark Cuban

Updated Category News Views 216

Empowering Teens Through Innovative AI Bootcamp Time is of the essence for high school students eager to launch their careers in technology with the Mark Cuban Foundation's Artificial Intelligence (AI) Bootcamp. Hosted by Girls Inc., this remarkable initiative opens doors for teens interested in the cutting-edge realm of AI. Applications for participation are set to close...

Continue Reading
BlackRock's Major Acquisition of Global Infrastructure Partners

Updated Category News Views 275

BlackRock Secures $12.5 Billion Deal The U.S. Federal Energy Regulatory Commission has recently approved BlackRock's substantial acquisition of Global Infrastructure Partners, valued at $12.5 billion. This approval is a pivotal moment for BlackRock as it seeks to broaden its reach within the infrastructure investment sector. Details of the Acquisition In this significant...

Continue Reading
Key Analyst Initiations Impacting Major Stocks This Week

Updated Category News Views 120

Recent Analyst Initiations: An Overview In the dynamic realm of stock trading, the insights of analysts can have a major impact on market trends. Recently, Wall Street has made significant adjustments to their ratings for several well-known stocks. Below, we summarize the latest analyst actions that may affect investor decisions this week. Arm Holdings plc (NASDAQ: ARM)...

Continue Reading